Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Intentional product misuse? 1,011 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,011 reports of Intentional product misuse have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 2.8% of all adverse event reports for ROSUVASTATIN.

1,011
Reports of Intentional product misuse with ROSUVASTATIN
2.8%
of all ROSUVASTATIN reports
19
Deaths
221
Hospitalizations

How Dangerous Is Intentional product misuse From ROSUVASTATIN?

Of the 1,011 reports, 19 (1.9%) resulted in death, 221 (21.9%) required hospitalization, and 25 (2.5%) were considered life-threatening.

Is Intentional product misuse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 1,011 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Intentional product misuse?

ETANERCEPT (3,992) PREGABALIN (3,731) BUDESONIDE\FORMOTEROL (3,399) ACETAMINOPHEN (2,924) ESOMEPRAZOLE (2,852) MINOXIDIL (2,418) TOFACITINIB (2,331) CINACALCET (2,092) QUETIAPINE (1,855) ALPRAZOLAM (1,709)

Which ROSUVASTATIN Alternatives Have Lower Intentional product misuse Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Intentional product misuse Reports All Drugs Causing Intentional product misuse ROSUVASTATIN Demographics